Pluri Inc (PLUR)
5.75
+0.11
(+1.95%)
USD |
NASDAQ |
May 03, 16:00
Pluri SG&A Expense (Quarterly): 2.354M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.354M |
September 30, 2023 | 2.438M |
June 30, 2023 | 3.124M |
March 31, 2023 | 3.02M |
December 31, 2022 | 2.896M |
September 30, 2022 | 2.74M |
June 30, 2022 | 3.521M |
March 31, 2022 | 4.553M |
December 31, 2021 | 4.288M |
September 30, 2021 | 5.088M |
June 30, 2021 | 6.102M |
March 31, 2021 | 6.559M |
December 31, 2020 | 5.097M |
September 30, 2020 | 2.799M |
June 30, 2020 | 2.677M |
March 31, 2020 | 1.682M |
December 31, 2019 | 1.75M |
September 30, 2019 | 1.813M |
June 30, 2019 | 2.351M |
March 31, 2019 | 2.473M |
December 31, 2018 | 2.123M |
September 30, 2018 | 2.21M |
June 30, 2018 | 2.844M |
March 31, 2018 | 2.666M |
December 31, 2017 | 2.92M |
Date | Value |
---|---|
September 30, 2017 | 2.763M |
June 30, 2017 | 2.031M |
March 31, 2017 | 1.886M |
December 31, 2016 | 1.446M |
September 30, 2016 | 1.564M |
June 30, 2016 | 1.814M |
March 31, 2016 | 1.639M |
December 31, 2015 | 1.546M |
September 30, 2015 | 1.487M |
June 30, 2015 | 1.742M |
March 31, 2015 | 1.527M |
December 31, 2014 | 1.513M |
September 30, 2014 | 1.678M |
June 30, 2014 | 2.341M |
March 31, 2014 | 2.531M |
December 31, 2013 | 1.975M |
September 30, 2013 | 1.829M |
June 30, 2013 | 1.389M |
March 31, 2013 | 1.159M |
December 31, 2012 | 1.42M |
September 30, 2012 | 1.681M |
June 30, 2012 | 1.732M |
March 31, 2012 | 1.924M |
December 31, 2011 | 1.275M |
September 30, 2011 | 1.637M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
1.682M
Minimum
Mar 2020
6.559M
Maximum
Mar 2021
3.413M
Average
2.896M
Median
Dec 2022
SG&A Expense (Quarterly) Benchmarks
InspireMD Inc | 4.278M |
Taro Pharmaceutical Industries Ltd | 50.41M |
BiomX Inc | 2.597M |
Alpha Tau Medical Ltd | 2.453M |
Holdco Nuvo Group DG Ltd | -- |